Diabetes technology: A primer highlighting the role of the pharmacist

Document Type

Article

Publication Date

11-2022

Abstract

The rapid advancement of technology has ushered in a new era of diabetes management, especially with regard to continuous glucose monitoring (CGM) and insulin delivery systems. Technology is changing at a fast pace and these tools can be unknown or confusing to people with diabetes. Pharmacists can play a major role in reducing barriers and facilitating shared decision-making regarding the individualization of technology in diabetes care. The Endocrine and Metabolism PRN Research Committee solicited the PRN membership to draft an opinion paper on diabetes technology using the Identify-Configure-Collaborate (ICC) framework from the Association of Diabetes Care and Education Specialists. The primary goal of the opinion paper is to provide an educational primer to health care professionals interested in learning more about the emerging diabetes technology landscape and highlight the role of the pharmacist within the ICC framework.

Publication Title

JACCP: Journal of the American College of Clinical Pharmacy

Volume

5

Issue

12

First Page

1307

Last Page

1323

Comments

This article was published in Journal of the American College of Clinical Pharmacy, Volume 5, Issue 12, pages 1307-1323.

The published version is available at https://doi.org/10.1002/jac5.1733.

Copyright © 2022 Pharmacotherapy Publications, Inc.

This document is currently not available here.

COinS